These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 25283278)
1. Comparison of LUMIPULSE(®) G1200 With Kryptor and Modular E170 for the Measurement of Seven Tumor Markers. Marlet J; Bernard M J Clin Lab Anal; 2016 Jan; 30(1):5-12. PubMed ID: 25283278 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of Lumipulse® G1200 for the measurement of six tumor markers: Comparison with AIA® 2000. de Rancher MR; Oudart JB; Maquart FX; Monboisse JC; Ramont L Clin Biochem; 2016 Nov; 49(16-17):1302-1306. PubMed ID: 27521619 [TBL] [Abstract][Full Text] [Related]
3. Clinical Utility and Cross-Reactivity of Insulin and C-Peptide Assays by the Lumipulse G1200 System. Oh J; Kim JH; Park HD Ann Lab Med; 2018 Nov; 38(6):530-537. PubMed ID: 30027696 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of a CLEIA automated assay system for the detection of a panel of tumor markers. Falzarano R; Viggiani V; Michienzi S; Longo F; Tudini S; Frati L; Anastasi E Tumour Biol; 2013 Oct; 34(5):3093-100. PubMed ID: 23775009 [TBL] [Abstract][Full Text] [Related]
5. Analytical evaluation of Lumipulse® BRAHMS PCT CLEIA assay and clinical performances in an unselected population as compared with central lab PCT assay. Dupuy AM; Né M; Bargnoux AS; Badiou S; Cristol JP Clin Biochem; 2017 Mar; 50(4-5):248-250. PubMed ID: 27838408 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new automated immunoassay for the quantification of anti-Müllerian hormone. Lotierzo M; Urbain V; Dupuy AM; Cristol JP Pract Lab Med; 2021 May; 25():e00220. PubMed ID: 34095410 [TBL] [Abstract][Full Text] [Related]
7. Performance evaluation of LUMIPULSE G1200 autoimmunoanalyzer for the detection of serum hepatitis B virus markers. Choi SJ; Park Y; Lee EY; Kim S; Kim HS J Clin Lab Anal; 2013 May; 27(3):204-6. PubMed ID: 23440745 [TBL] [Abstract][Full Text] [Related]
8. Imprecision of tumour biomarker measurements on Roche Modular E170 platform fulfills desirable goals derived from biological variation. Dolci A; Scapellato L; Mozzi R; Panteghini M Ann Clin Biochem; 2010 Mar; 47(Pt 2):171-3. PubMed ID: 20144978 [TBL] [Abstract][Full Text] [Related]
10. Performance evaluation of serum PIVKA-II measurement using HISCL-5000 and a method comparison of HISCL-5000, LUMIPULSE G1200, and ARCHITECT i2000. Ryu MR; Kang ES; Park HD J Clin Lab Anal; 2019 Jul; 33(6):e22921. PubMed ID: 31131509 [TBL] [Abstract][Full Text] [Related]
11. Assessment of the Concordance and Diagnostic Accuracy Between Elecsys and Lumipulse Fully Automated Platforms and Innotest. Dakterzada F; López-Ortega R; Arias A; Riba-Llena I; Ruiz-Julián M; Huerto R; Tahan N; Piñol-Ripoll G Front Aging Neurosci; 2021; 13():604119. PubMed ID: 33746733 [TBL] [Abstract][Full Text] [Related]
12. Verification of the harmonization of human epididymis protein 4 assays. Ferraro S; Borille S; Carnevale A; Frusciante E; Bassani N; Panteghini M Clin Chem Lab Med; 2016 Oct; 54(10):1635-43. PubMed ID: 27028735 [TBL] [Abstract][Full Text] [Related]
13. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA). Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221 [TBL] [Abstract][Full Text] [Related]
14. Automated measurement of 25-OH Vitamin D on the LUMIPULSE Parra M; Foj L; Filella X Br J Biomed Sci; 2016 Jul; 73(3):104-109. PubMed ID: 27310165 [TBL] [Abstract][Full Text] [Related]
15. Results from a multicenter evaluation of the 4th generation Elecsys Troponin T assay. Hermsen D; Apple F; Garcia-Beltràn L; Jaffe A; Karon B; Lewandrowski E; Mühlbacher A; Müller R; Ordóñez J; Pagani F; Panteghini M; Plecko T; Jarausch J Clin Lab; 2007; 53(1-2):1-9. PubMed ID: 17323819 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Four Automated Carcinoembryonic Antigen Immunoassays: ADVIA Centaur XP, ARCHITECT I2000sr, Elecsys E170, and Unicel Dxi800. Park J; Lee S; Kim Y; Choi A; Lee H; Lim J; Kim Y; Han K; Oh EJ Ann Lab Med; 2018 Jul; 38(4):355-361. PubMed ID: 29611386 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the test methods (KRYPTOR, ES 600 and CIS-RIA) for CEA, CA 15-3 and CA 125 follow-up and ONCOCHECK-quality control. Bauer T; Charl S; Sturm G Anticancer Res; 2000; 20(6D):5245-7. PubMed ID: 11326703 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the UniCel™ DxI 800 immunoassay analyzer in measuring five tumor markers. Park Y; Park Y; Park J; Kim HS Yonsei Med J; 2012 May; 53(3):557-64. PubMed ID: 22477000 [TBL] [Abstract][Full Text] [Related]
19. Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Aβ Bayart JL; Hanseeuw B; Ivanoiu A; van Pesch V J Neurol; 2019 Sep; 266(9):2304-2311. PubMed ID: 31179518 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic and analytical performance of the hepatitis B core related antigen immunoassay in hepatitis B patients. van Halewijn GJ; Geurtsvankessel CH; Klaasse J; van Oord GW; de Knegt RJ; van Campenhout MJ; Boonstra A; van der Eijk AA J Clin Virol; 2019 May; 114():1-5. PubMed ID: 30852396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]